1. Home
  2. GDL vs XTNT Comparison

GDL vs XTNT Comparison

Compare GDL & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GDL Fund The of Beneficial Interest

GDL

GDL Fund The of Beneficial Interest

HOLD

Current Price

$8.53

Market Cap

94.4M

Sector

Finance

ML Signal

HOLD

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.58

Market Cap

86.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDL
XTNT
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.4M
86.2M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
GDL
XTNT
Price
$8.53
$0.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
11.3K
153.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
6.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
N/A
$53,337,000.00
Revenue This Year
N/A
$15.08
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$19.34
Revenue Growth
N/A
N/A
52 Week Low
$7.71
$0.34
52 Week High
$8.67
$0.95

Technical Indicators

Market Signals
Indicator
GDL
XTNT
Relative Strength Index (RSI) 52.50 39.07
Support Level $8.38 $0.55
Resistance Level $8.62 $0.68
Average True Range (ATR) 0.09 0.03
MACD -0.00 0.00
Stochastic Oscillator 69.01 29.09

Price Performance

Historical Comparison
GDL
XTNT

About GDL GDL Fund The of Beneficial Interest

GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: